Sort
51,593 grants matching “hepatitis”
Software for predicting liver injury from biologics drug candidates using data from a human liver microphysiology system
$862,693Kyunghee Yang · Simulations Plus, Inc. · R44 · FY2022 · TR
A new humanized mouse model to study HBV gene editing
$862,440Keith R Jerome · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
Biofilm Epidemiology and Mechanisms in Colon Cancer
$862,426Cynthia L Sears · Johns Hopkins University · R01 · FY2018 · CA
Apolipoprotein C3-loading of apolipoprotein B100 lipoproteins and cardiovascular disease in patients with type 1 diabetes
$862,314Jay W Heinecke · University Of Washington · R01 · FY2022 · HL
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)
$862,255David W Crabb · Indiana University Indianapolis · U01 · FY2016 · AA
Genetic Determinants of Antidepressant Response
$862,242Francis J McMahon · National Institute Of Mental Health · ZIA · FY2012 · MH
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
$861,956Raymond Luke Comenzo · Tufts Medical Center · R01 · FY2024 · CA
P75 Small Molecule Ligands for Alzheimer's Therapy
$861,856Frank M Longo · Stanford University · U01 · FY2009 · AG
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
$861,780Beth Israel Medical Ctr (New York) · U01 · FY2000 · AI
Natural History of Hepatitis C Infection in HIV Disease
$861,647Boston University Medical Campus · R01 · FY2005 · DA
Directed Transport Physics and Muli-Scale Therapy of Colon Cancer Liver Metatasis
$861,642Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2010 · CA
Improving Hepatitis C Treatment in Injection Drug Users
$861,193Upstate Medical University · R01 · FY2005 · DA
Cost-Effectiveness of Preventing HIV Complications
$861,119Kenneth Alan Freedberg · Massachusetts General Hospital · R01 · FY2016 · AI
Task 4: The Interventional Agent Development Services program
$860,629Jon Carl Mirsalis · Sri International · N01 · FY2014 · AI
MGMT OF INFO RESOURCES ON THERAPEUTIC AGENTS FOR HIV AND OPPORTUNISTIC INFECTIONS
$860,506Margaret Rush · Gryphon Scientific, Llc · N01 · FY2011 · AI
Amino Acids and Pediatric Hepatic Steatosis
$860,498Robert R Wolfe · Amino Company Llc, The · R44 · FY2024 · DK
Multidisciplinary Studies of Hematopoietic Malignancies
$860,372Lindsay Morton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
HEPATITIS C IN NEW IDUS: IMPLICATIONS FOR HIV PREVENTION
$860,023New York Academy Of Medicine · R01 · FY2002 · DA
Studies of Atomic Bomb Survivors
$860,011Kiyohiko Mabuchi · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
The role of cancer stem cells in liver cancer heterogeneity and subtypes
$859,473Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
HIV and musculoskeletal frailty: implications for care, policy and research
$859,206Elena Losina · Brigham And Women'S Hospital · R01 · FY2023 · NR
Cost-Effectiveness of Preventing HIV Complications
$858,653Kenneth Alan Freedberg · Massachusetts General Hospital · R01 · FY2017 · AI
A therapeutic vaccine for chronic hepatitis B
$858,609David R. Milich · Vlp Biotech, Inc. · R44 · FY2020 · AI
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
$858,575John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DK
Center for the Study of Innate Immunity to HCV Infection
$858,518Michael J Gale · University Of Washington · U19 · FY2012 · AI